Figure A-6. Scope of microbial risk assessment for current portfolio of agents planned for MCMT&EF. For plague infections from accidental exposures in the laboratory, pathways are identified by solid purple lines for observed exposures in recent laboratory associated infections (LAIs) and by dashed purple lines for possible exposures. Unlikely scenarios are excluded (gray text box borders). Supporting evidence and rationale will be provided for all pathways in the qualitative risk assessment section.